Microbicide Trials Network

MTN-004

A study that evaluated the safety, acceptability and ease of use of the microbicide candidate VivaGel® in sexually active, HIV-negative women ages 18 to 24.

 

See

Phase I Study Finds Candidate Microbicide VivaGel Generally Well Tolerated but Women Less Willing to Use It

25-May-2010

  

Safety of new microbicide for HIV prevention to be tested in young women in U.S. trial

9-July-2007

      

MTN-004 Backgrounder

25-May-2010

     

MTN-004 Q&A

25-May-2010

 

See Also

MTN-004 Study Protocol